Ceradyne, Inc. (CRDN) Misses Q1 EPS Views; Cuts FY12 Outlook
Tweet
Share
E-mailGet Alerts CRDN Hot Sheet
Price: $35.00 --0%
Financial Fact:
INCOME BEFORE PROVISION FOR INCOME TAXES: -17.36M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
INCOME BEFORE PROVISION FOR INCOME TAXES: -17.36M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Ceradyne, Inc. (NASDAQ: CRDN) reported Q1 EPS of $0.16, $0.21 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $106.3 million versus the consensus estimate of $120.08 million.
Ceradyne, Inc. sees FY2012 EPS of $1.40-$1.65, versus prior guidance of $2.30-$2.65 and the consensus of $2.40. Ceradyne, Inc. sees FY2012 revenue of $540-$565 million, versus prior guidance of $590-$625 million and the consensus of $595.80 million.
For earnings history and earnings-related data on Ceradyne, Inc. (CRDN) click here.
Ceradyne, Inc. sees FY2012 EPS of $1.40-$1.65, versus prior guidance of $2.30-$2.65 and the consensus of $2.40. Ceradyne, Inc. sees FY2012 revenue of $540-$565 million, versus prior guidance of $590-$625 million and the consensus of $595.80 million.
For earnings history and earnings-related data on Ceradyne, Inc. (CRDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Omega Flex (OFLX) Tops Q2 EPS by 27c
- Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
